STOCK TITAN

Leap Therapeutics, Inc. (LPTX) Net Income by Year

LPTX

Leap Therapeutics, Inc. reported $5.0M in net income in fiscal year 2025. This represents an increase of 107.4% from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Leap Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income $5.0M
YoY +107.4%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LPTX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY22FY21FY20FY19FY18FY17FY16
Net Income$5.0M+107.4%-$68.0M+16.0%-$81.0M-48.4%-$54.6M-34.5%-$40.6M-47.5%-$27.5M+16.4%-$32.9M-42.2%-$23.1M+22.2%-$29.7M-16.0%-$25.6M

LPTX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'24Q4'23Q3'23Q2'23
Net Income-$77.2M-399.9%N/A-$3.3M+81.8%-$16.6M+17.3%-$15.4M-11.7%N/A-$18.2M-32.7%-$20.1M-50.3%-$13.8M+67.0%N/A-$13.7M+9.3%-$13.4M+21.3%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Leap Therapeutics, Inc. financials

Frequently Asked Questions

What was Leap Therapeutics, Inc.'s net income in fiscal year 2025?

Leap Therapeutics, Inc. reported $5.0M in net income in fiscal year 2025.

How fast is Leap Therapeutics, Inc.'s net income growing?

Leap Therapeutics, Inc. (LPTX) net income rose by 107.4% year over year, from -$68.0M to $5.0M in fiscal year 2025.

How has Leap Therapeutics, Inc.'s net income changed over the years?

Across the 10 fiscal years this page covers, Leap Therapeutics, Inc. (LPTX) net income went from -$25.6M in fiscal year 2016 to $5.0M in fiscal year 2025.

Leap Therapeutics, Inc. (LPTX) reported -$77.2M in net income in Q1 2026. This represents a decrease of 399.9% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Leap Therapeutics, Inc. (LPTX) reported on that line in every period on record.